Vimarsana
Biggest News Aggregation in the World

Page 12 - Cures Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cures Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cures Act Today - Breaking & Trending Today

Should Patients Get Immediate Access to Cancer Test Results? - Vimarsana News

Should Patients Get Immediate Access to Cancer Test Results?

Does instant access to life-changing test results help or harm patients? Esteemed oncologists Aaron Goodman and Mark Lewis debate the pros and cons of electronic health records.

Doctor pay hits roadblocks in the House - Vimarsana News

Doctor pay hits roadblocks in the House

The chaos in the House in choosing a new speaker and the friction between the two parties during a subcommittee hearing makes a wholesale reform effort appear unlikely this year.

KLAS spotlights vendors making EHRs work better for providers - Vimarsana News

KLAS spotlights vendors making EHRs work better for providers

While lack of efficiency in using electronic health records is most correlated with clinician burnout, healthcare organizations want vendors to help them improve EHR experiences, according to the KLAS Arch Collaborative.

DPharm 2023 deep dive: IQVIA on patients and tech for trials - Vimarsana News

DPharm 2023 deep dive: IQVIA on patients and tech for trials

At DPharm 2023, there was a huge meeting of minds to discuss the latest innovations in clinical trials. Outsourcing Pharma was delighted to have an in-depth discussion with IQVIA’s Elan Josielewski, senior principal and head of operations, patient centred solutions and Anthony Mikulaschek, vice president of electronical clinical outcomes assessment (eCOA).

U.S. Food and Drug Administration Kicks Off Fall with Several Impactful Medical Product Guidances | Wilson Sonsini Goodrich & Rosati - Vimarsana News

U.S. Food and Drug Administration Kicks Off Fall with Several Impactful Medical Product Guidances | Wilson Sonsini Goodrich & Rosati

The U.S. Food and Drug Administration (FDA) is making efforts to modernize both the 510(k) approval process for medical devices and study designs for drugs and biologics.